News/Compliance & Enforcement/Radeas to to Pay $11.6 Million for Fraudulent Billing and Kickbacks in Unnecessary Drug Testing Scheme

News·Compliance & Enforcement Brief

Radeas to to Pay $11.6 Million for Fraudulent Billing and Kickbacks in Unnecessary Drug Testing Scheme

PubK AdminApril 8, 2022 · 1 min read

🔒 Members Only

Radeas LLC of North Carolina has agreed to pay $11.6 million to resolve allegations that it billed Medicare for medically unnecessary urine drug tests from 2016 to 2021, and had paid kickbacks since 2013.

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.

$750/year

Become a Member

Not ready to join? Take the free Pub K Weekly digest.One email. Free. Top industry articles, the community calendar, and the latest job postings.